AU2001262736A1 - Apoptosis inducers, caspase cascade activators and anticancer agents - Google Patents

Apoptosis inducers, caspase cascade activators and anticancer agents

Info

Publication number
AU2001262736A1
AU2001262736A1 AU2001262736A AU6273601A AU2001262736A1 AU 2001262736 A1 AU2001262736 A1 AU 2001262736A1 AU 2001262736 A AU2001262736 A AU 2001262736A AU 6273601 A AU6273601 A AU 6273601A AU 2001262736 A1 AU2001262736 A1 AU 2001262736A1
Authority
AU
Australia
Prior art keywords
anticancer agents
caspase cascade
apoptosis inducers
cascade activators
activators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001262736A
Inventor
Yoko Matsumoto
Ryuichi Ueoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kimigafuchi Gakuen
Original Assignee
Kimigafuchi Gakuen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kimigafuchi Gakuen filed Critical Kimigafuchi Gakuen
Publication of AU2001262736A1 publication Critical patent/AU2001262736A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001262736A 2000-09-29 2001-06-11 Apoptosis inducers, caspase cascade activators and anticancer agents Abandoned AU2001262736A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-299631 2000-09-29
JP2000299631 2000-09-29
PCT/JP2001/004903 WO2002028399A1 (en) 2000-09-29 2001-06-11 Apoptosis inducers, caspase cascade activators and anticancer agents

Publications (1)

Publication Number Publication Date
AU2001262736A1 true AU2001262736A1 (en) 2002-04-15

Family

ID=18781411

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001262736A Abandoned AU2001262736A1 (en) 2000-09-29 2001-06-11 Apoptosis inducers, caspase cascade activators and anticancer agents

Country Status (6)

Country Link
US (1) US20040043918A1 (en)
EP (1) EP1329219A4 (en)
JP (1) JPWO2002028399A1 (en)
AU (1) AU2001262736A1 (en)
CA (1) CA2435976A1 (en)
WO (1) WO2002028399A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4891522B2 (en) * 2003-10-03 2012-03-07 株式会社ファンケル Serum GOT, GPT improving agent
EP1745788A1 (en) * 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acyglycerophospholipids for treating cancer and cachexia
ITMI20101872A1 (en) * 2010-10-13 2012-04-14 Vincenzo Cinosi USE OF PHOSPHATIDYLCOLINE IN THE TREATMENT OF CANCER
WO2014196621A1 (en) * 2013-06-07 2014-12-11 Ｋｔｎバイオテック株式会社 Anticancer drug
EP3000471A1 (en) * 2014-09-28 2016-03-30 Bernhard-Nocht-Institut für Tropenmedizin Novel immunostimulatory molecules
KR20190019121A (en) * 2016-06-17 2019-02-26 오사카 유니버시티 Intratumoral intravenous growth promoter

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03106821A (en) * 1989-09-20 1991-05-07 Denki Kagaku Kogyo Kk Antitumor agent
JPH03275625A (en) * 1990-03-23 1991-12-06 Nippon Oil & Fats Co Ltd Carcinostatic agent and production thereof
US5858397A (en) * 1995-10-11 1999-01-12 University Of British Columbia Liposomal formulations of mitoxantrone
US20020127273A1 (en) * 2000-09-15 2002-09-12 Aronex Pharmaceuticals, Inc. Liposomal nystatin treatment of fungal infection

Also Published As

Publication number Publication date
JPWO2002028399A1 (en) 2004-02-12
CA2435976A1 (en) 2002-04-11
EP1329219A1 (en) 2003-07-23
US20040043918A1 (en) 2004-03-04
WO2002028399A1 (en) 2002-04-11
EP1329219A4 (en) 2004-10-20

Similar Documents

Publication Publication Date Title
MXPA03004644A (en) Phenylacetamido- pyrazole derivatives and their use as antitumor agents.
MXPA02001508A (en) Arylmethylcarbonylaminothiazole derivatives and their use as antitumor agents.
AU2002228922A1 (en) Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof
ZA200204390B (en) Caspase inhibitors and uses thereof.
MXPA03004947A (en) Tetralone derivatives as antitumor agents.
MXPA03005432A (en) Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands.
AU2002224595A1 (en) Antitumor agents
HK1058319A1 (en) Carrier with solid fibrinogen and solid thrombin.
AU2002243246A1 (en) Cddo-compounds and combination therapies thereof
AU2002323180A1 (en) Hydroxypyridonate and hydroxypyrimidinone chelating agents
GB0111581D0 (en) Consumable goods and services providing system
ZA979095B (en) HIV and cancer treatments.
AU2002211717A1 (en) Stresscopins and their uses
AU2001245659A1 (en) Pyrazolate copper complexes, and mocvd of copper using same
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001262736A1 (en) Apoptosis inducers, caspase cascade activators and anticancer agents
ZA992572B (en) Spirit chiller.
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU4576299A (en) Caspases and apoptosis
AU7625500A (en) Caspases and apoptosis
AU2001267589A1 (en) Cycloalkyl - or cycloalkylmethyl-substituted 6-phenylphenanthridines
CA99163S (en) Dual speaker box
CA99734S (en) Safety cone
CA97089S (en) Door
AU2001263891A1 (en) Noise screens, their components and their construction